To investigate whether calmodulin is dysregulated in MASLD, we first assessed the mRNA expression levels of Calm1, Calm2, and Calm3 in mouse models of MASLD, which were found to be significantly reduced in the livers of HFD mice (Figure 9a). This evidence concerns the gene CALM2 and metabolic dysfunction-associated steatotic liver disease.